Literature DB >> 26767378

Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.

Elias K Mai1, Thomas Hielscher2, Jost K Kloth3, Maximilian Merz4, Sofia Shah4, Michaela Hillengass4, Barbara Wagner4, Dirk Hose4, M S Raab4, Anna Jauch5, Stefan Delorme6, Hartmut Goldschmidt4,7, Marc-André Weber3, Jens Hillengass4,6.   

Abstract

OBJECTIVE: To assess associations between bone marrow infiltration patterns and localization in magnetic resonance imaging (MRI) and baseline clinical/prognostic parameters in multiple myeloma (MM).
METHODS: We compared baseline MM parameters, MRI patterns and localization of focal lesions to the mineralized bone in 206 newly diagnosed MM patients.
RESULTS: A high tumour mass (represented by International Staging System stage III) was significantly associated with severe diffuse infiltration (p = 0.015) and a higher number of focal lesions (p = 0.006). Elevated creatinine (p = 0.003), anaemia (p < 0.001) and high LDH (p = 0.001) correlated with severe diffuse infiltration. A salt and pepper diffuse pattern had a favourable prognosis. A higher degree of destruction of mineralized bone (assessed by X-ray or computed tomography) was associated with an increasing number of focal lesions on MRI (p < 0.001). Adverse cytogenetics (del17p/gain1q21/t(4;14)) were associated with diffuse infiltration (p = 0.008). The presence of intraosseous focal lesions exceeding the mineralized bone had a borderline significant impact on prognosis.
CONCLUSIONS: Diffuse bone marrow infiltration on MRI correlates with adverse cytogenetics, lowered haemoglobin values and high tumour burden in newly diagnosed MM whereas an increasing number of focal lesions correlates with a higher degree of bone destruction. Focal lesions exceeding the cortical bone did not adversely affect the prognosis. KEY POINTS: • Diffuse MRI correlates with adverse cytogenetics, lowered haemoglobin and high tumour burden. • Higher numbers of MRI focal lesions correlate with increasing degree of bone destruction. • Focal lesions exceeding the cortical bone borderline significantly influence survival. • Moderate/severe diffuse infiltration and more than 23 focal lesions adversely affect survival.

Entities:  

Keywords:  Bone marrow; Magnetic resonance imaging; Multiple myeloma; Plasma cells; Prognosis

Mesh:

Year:  2016        PMID: 26767378     DOI: 10.1007/s00330-015-4195-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Authors:  Jens Hillengass; Kerstin Fechtner; Marc-André Weber; Tobias Bäuerle; Sofia Ayyaz; Christiane Heiss; Thomas Hielscher; Thomas M Moehler; Gerlinde Egerer; Kai Neben; Anthony D Ho; Hans-Ulrich Kauczor; Stefan Delorme; Hartmut Goldschmidt
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

2.  Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.

Authors:  Jens Hillengass; Klaus Wasser; Stefan Delorme; Fabian Kiessling; Christian Zechmann; Axel Benner; Hans-Ulrich Kauczor; Anthony D Ho; Hartmut Goldschmidt; Thomas M Moehler
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

3.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.

Authors:  A Stäbler; A Baur; R Bartl; R Munker; R Lamerz; M F Reiser
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

4.  Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.

Authors:  L A Moulopoulos; D Gika; A Anagnostopoulos; K Delasalle; D Weber; R Alexanian; M A Dimopoulos
Journal:  Ann Oncol       Date:  2005-08-08       Impact factor: 32.976

5.  Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma.

Authors:  Jens Hillengass; Sofia Ayyaz; Kerstin Kilk; Marc-André Weber; Thomas Hielscher; Rajiv Shah; Dirk Hose; Stefan Delorme; Hartmut Goldschmidt; Kai Neben
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

6.  Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.

Authors:  F E Lecouvet; B C Vande Berg; L Michaux; J Malghem; B E Maldague; J Jamart; A Ferrant; J L Michaux
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

7.  Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.

Authors:  Tobias Bäuerle; Jens Hillengass; Kerstin Fechtner; Christian M Zechmann; Lars Grenacher; Thomas M Moehler; Heiss Christiane; Barbara Wagner-Gund; Kai Neben; Hans-Ulrich Kauczor; Hartmut Goldschmidt; Stefan Delorme
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

8.  Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.

Authors:  Maximilian Merz; Thomas M Moehler; Judith Ritsch; Tobias Bäuerle; Christian M Zechmann; Barbara Wagner; Anna Jauch; Dirk Hose; Christina Kunz; Thomas Hielscher; Hendrik Laue; Hartmut Goldschmidt; Stefan Delorme; Jens Hillengass
Journal:  Eur Radiol       Date:  2015-07-29       Impact factor: 5.315

9.  Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.

Authors:  Sikander Ailawadhi; Ahmed N Abdelhalim; Lyudmyla Derby; Terry L Mashtare; Kena C Miller; Gregory E Wilding; Ronald A Alberico; Ronald Gottlieb; Donald L Klippenstein; Kelvin Lee; Asher A Chanan-Khan
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

10.  Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.

Authors:  Jost K Kloth; Jens Hillengass; Karin Listl; Kerstin Kilk; Thomas Hielscher; Ola Landgren; Stefan Delorme; Hartmut Goldschmidt; Hans-Ulrich Kauczor; Marc-André Weber
Journal:  Int J Cancer       Date:  2014-04-17       Impact factor: 7.396

View more
  6 in total

Review 1.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

2.  The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.

Authors:  Leo Rasche; Edgardo J Angtuaco; Terri L Alpe; Grant H Gershner; James E McDonald; Rohan S Samant; Manoj Kumar; Rudy Van Hemert; Joshua Epstein; Shayu Deshpande; Ruslana Tytarenko; Shmuel Yaccoby; Jens Hillengass; Sharmilan Thanendrarajan; Carolina Schinke; Frits van Rhee; Maurizio Zangari; Brian A Walker; Bart Barlogie; Gareth J Morgan; Faith E Davies; Niels Weinhold
Journal:  Blood       Date:  2018-05-21       Impact factor: 22.113

Review 3.  Modern radiographic imaging in multiple myeloma, what is the minimum requirement?

Authors:  Esther Mena; Evrim B Turkbey; Liza Lindenberg
Journal:  Semin Oncol       Date:  2022-01-20       Impact factor: 5.385

Review 4.  Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors:  Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

Review 5.  Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.

Authors:  Robin W Jansen; Paul van Amstel; Roland M Martens; Irsan E Kooi; Pieter Wesseling; Adrianus J de Langen; Catharina W Menke-Van der Houven van Oordt; Bernard H E Jansen; Annette C Moll; Josephine C Dorsman; Jonas A Castelijns; Pim de Graaf; Marcus C de Jong
Journal:  Oncotarget       Date:  2018-04-13

6.  Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT.

Authors:  S C Brandelik; S Skornitzke; T Mokry; S Sauer; W Stiller; J Nattenmüller; H U Kauczor; T F Weber; T D Do
Journal:  Eur Radiol       Date:  2021-03-30       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.